Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
March 7, 1998
[Mixed secretory and obstructive azoospermia. Transseptal vasovasostomy by vas deferens transposition: a case report and review of the literature]
T Lebret, J M Hervé, F Merlet, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
June 30, 2009
[The impact of partial nephrectomy on morbidity and on long-term oncological outcomes]
Y Rouach, M-O Timsit, T Lebret, et al.
European Urology
|
June 1, 2000
Prognostic value of MIB-1 antibody labeling index to predict response to Bacillus Calmette-Guérin therapy in a high-risk selected population of patients with stage T1 grade G3 bladder cancer
T Lebret, V Becette, J M Hervé, et al.
British Journal of Urology
|
August 1, 1981
Combined chemotherapy in the management of metastatic bladder cancer
E Garcia-Giralt, J Auvert, A T Lachand, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
June 5, 2012
[Are therapeutics decisions homogeneous in multidisciplinary onco-urology staff meeting? Comparison of therapeutic options taken in four departments from Paris]
F Audenet, V Lejay, A Mejean, et al.
European Urology
|
December 26, 2001
EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU)
K G Naber, B Bergman, M C Bishop, et al.
British Journal of Pharmacology
|
September 26, 2012
Effects of ρ-Da1a a peptidic α(1) (A) -adrenoceptor antagonist in human isolated prostatic adenoma and anaesthetized rats
S Palea, A Maiga, V Guilloteau, et al.
Progress in Clinical and Biological Research
|
January 1, 1987
Anandron (RU 23908) associated to surgical castration in previously untreated stage D prostate cancer: a multicenter comparative study of two doses of the drug and of a placebo
J M Brisset, L Boccon-Gibod, H Botto, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 11, 1999
[Study of the Ki-67 antibody immunolabeling of renal adenocarcinomas with or without renal vein thrombosis]
T Lebret, V Becette, A Colau, et al.
European Urology
|
January 1, 1993
European collaborative study of antibiotic prophylaxis for transurethral resection of the prostate
T B Hargreave, H Botto, G H Rikken, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
March 7, 1998
[Mixed secretory and obstructive azoospermia. Transseptal vasovasostomy by vas deferens transposition: a case report and review of the literature]
T Lebret, J M Hervé, F Merlet, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
June 30, 2009
[The impact of partial nephrectomy on morbidity and on long-term oncological outcomes]
Y Rouach, M-O Timsit, T Lebret, et al.
European Urology
|
June 1, 2000
Prognostic value of MIB-1 antibody labeling index to predict response to Bacillus Calmette-Guérin therapy in a high-risk selected population of patients with stage T1 grade G3 bladder cancer
T Lebret, V Becette, J M Hervé, et al.
British Journal of Urology
|
August 1, 1981
Combined chemotherapy in the management of metastatic bladder cancer
E Garcia-Giralt, J Auvert, A T Lachand, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
June 5, 2012
[Are therapeutics decisions homogeneous in multidisciplinary onco-urology staff meeting? Comparison of therapeutic options taken in four departments from Paris]
F Audenet, V Lejay, A Mejean, et al.
European Urology
|
December 26, 2001
EAU guidelines for the management of urinary and male genital tract infections. Urinary Tract Infection (UTI) Working Group of the Health Care Office (HCO) of the European Association of Urology (EAU)
K G Naber, B Bergman, M C Bishop, et al.
British Journal of Pharmacology
|
September 26, 2012
Effects of ρ-Da1a a peptidic α(1) (A) -adrenoceptor antagonist in human isolated prostatic adenoma and anaesthetized rats
S Palea, A Maiga, V Guilloteau, et al.
Progress in Clinical and Biological Research
|
January 1, 1987
Anandron (RU 23908) associated to surgical castration in previously untreated stage D prostate cancer: a multicenter comparative study of two doses of the drug and of a placebo
J M Brisset, L Boccon-Gibod, H Botto, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
November 11, 1999
[Study of the Ki-67 antibody immunolabeling of renal adenocarcinomas with or without renal vein thrombosis]
T Lebret, V Becette, A Colau, et al.
European Urology
|
January 1, 1993
European collaborative study of antibiotic prophylaxis for transurethral resection of the prostate
T B Hargreave, H Botto, G H Rikken, et al.
Page
of 10